| Shweta Sethi, DPT | |
|
5 Samantha Way, Acton, MA 01720-4173 | |
| (978) 400-8610 | |
| Not Available |
| Full Name | Shweta Sethi |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 5 Samantha Way, Acton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780218776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 23272 (Massachusetts) | Secondary |
| 225100000X | Physical Therapist | 1340204 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ideal Physical Therapy Of Texas Llc | 0547583809 | 266 |
News Archive
Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer's than white women, suggests new research from the Keck School of Medicine of USC.
Nearly nine out of ten people (87 per cent) could be risking dangerous levels of skin damage, which can lead to skin cancer, because they are either not using the right amount of sunscreen, not sure of the amount they use or are not using any at all - according to a new survey by Superdrug and Cancer Research UK.
DiscoveRx Corp. and BioFocus® announced today that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus' customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.
› Verified 6 days ago
| Entity Name | Ideal Physical Therapy Of Texas Llc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1538573746 PECOS PAC ID: 0547583809 Enrollment ID: O20141218000890 |
News Archive
Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer's than white women, suggests new research from the Keck School of Medicine of USC.
Nearly nine out of ten people (87 per cent) could be risking dangerous levels of skin damage, which can lead to skin cancer, because they are either not using the right amount of sunscreen, not sure of the amount they use or are not using any at all - according to a new survey by Superdrug and Cancer Research UK.
DiscoveRx Corp. and BioFocus® announced today that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus' customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shweta Sethi, DPT 5 Samantha Way, Acton, MA 01720-4173 Ph: (978) 400-8610 | Shweta Sethi, DPT 5 Samantha Way, Acton, MA 01720-4173 Ph: (978) 400-8610 |
News Archive
Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer's than white women, suggests new research from the Keck School of Medicine of USC.
Nearly nine out of ten people (87 per cent) could be risking dangerous levels of skin damage, which can lead to skin cancer, because they are either not using the right amount of sunscreen, not sure of the amount they use or are not using any at all - according to a new survey by Superdrug and Cancer Research UK.
DiscoveRx Corp. and BioFocus® announced today that they have signed a co-marketing agreement that allows BioFocus to perform screening on behalf of BioFocus' customers using DiscoveRx PathHunter™ ß-Arrestin GPCR screening assay, HitHunter™ cAMP assays and associated cell lines.
› Verified 6 days ago